LAVA Therapeutics N.V. is a pharmaceutical company focused on developing novel cancer treatments using bispecific antibodies. With a cutting-edge platform and a strong pipeline of candidates, LAVA is poised to revolutionize cancer therapy and improve patient outcomes.
